Epilepsy & Seizures

Forward Thinking: Advances in Neurology

November/December 2017—A review of notable neurological developments in 2017 and a preview of the year ahead.

Oral Vimpat Approved for Use in Pediatric Patients with Partial-Onset Seizures

Tuesday, November 07, 2017—The FDA approved a label extension for Vimpat (lacosamide, UCB) CV as an oral option for the treatment of partial-onset seizures (POS) in pediatric patients four years an…

In-Focus: Charting a New Course to Seizure Freedom

October 2017— VIDEO NEWS Managing Epilepsy in Pregnancy and Postpartum “What’s important now is that we think about how we’re going to mana

Advanced Epilepsy Care: Identifying Candidates for Surgical Interventions

Barbara C. Jobst, MD

October 2017—A growing platform of surgical interventions may increase awareness, referrals, and utilization of advanced treatment.

Innovations in Functional Imaging of Epilepsy

Kathryn A. Davis, MD, MS

October 2017—Advances in noninvasive imaging should create more opportunities for physicians to localize treatment and optimize care.

The Ketogenic Diet: Overcoming Challenges for Optimal Utilization in Epilepsy Treatment

Amy Kao, MD

October 2017—Despite current logistical and clinical challenges, dietary therapy will play a significant role in epilepsy treatment for years to come.

Improving Care Delivery Systems in Pediatric Epilepsy

With Anup D. Patel, MD

October 2017—Broad implementation of new measures may help curb high utilization rates of emergency departments and improve overall care.

Next-Generation VNS System and Implantable Device Approved

Monday, October 09, 2017—LivaNova has received FDA approval for its next-generation Vagus Nerve Stimulation (VNS) Therapy Programming System for drug-resistant epilepsy. The FDA has also approved the …